Castle Biosciences, Inc.
← Back to CSTL Overview

Castle Biosciences, Inc. (CSTL)

Solvency & Capital Structure

Total Debt

$36.6M

Net Debt

-$230.2M

Castle Biosciences, Inc. currently has $36.6M in total debt. Net debt is -$230.2M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

CSTLQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-06-300.040.27-0.23Net Cash0.566.5%
2026-03-310.040.26-0.22Net Cash0.556.7%
2025-12-310.040.30-0.26Net Cash0.586.4%
2025-09-300.040.29-0.25Net Cash0.566.6%
2025-06-300.040.28-0.24Net Cash0.546.9%
2025-03-310.030.28-0.25Net Cash0.505.2%
2024-12-310.030.29-0.27Net Cash0.535.0%
2024-09-300.030.28-0.25Net Cash0.515.2%
2024-06-300.030.26-0.23Net Cash0.495.2%
2024-03-310.030.24-0.21Net Cash0.465.5%
2023-12-310.020.24-0.23Net Cash0.453.4%
2023-09-300.010.23-0.22Net Cash0.443.3%
2023-06-300.010.23-0.21Net Cash0.433.4%
2023-03-310.010.23-0.22Net Cash0.433.0%
2022-12-310.010.26-0.25Net Cash0.453.0%
2022-09-300.010.27-0.25Net Cash0.462.9%
2022-06-300.010.27-0.27Net Cash0.461.7%
2022-03-310.010.31-0.30Net Cash0.441.8%
2021-12-310.010.33-0.32Net Cash0.461.8%
2021-09-300.000.36-0.36Net Cash0.430.0%
2021-06-300.000.37-0.37Net Cash0.440.0%
2021-03-310.000.41-0.41Net Cash0.440.0%
2020-12-310.000.41-0.41Net Cash0.440.0%
2020-09-300.020.18-0.16Net Cash0.2110.7%
2020-06-300.020.18-0.16Net Cash0.2012.3%
2020-03-310.030.10-0.07Net Cash0.1221.1%
2019-12-310.030.10-0.07Net Cash0.1221.0%
2019-09-300.020.09-0.07Net Cash0.1122.0%
2019-06-300.030.020.010.0387.3%
2019-03-310.020.020.010.0376.3%
2018-12-310.020.000.020.02109.3%
2018-03-310.000.00-0.00Net Cash0.00
Castle Biosciences, Inc. (CSTL) Debt History — Total Debt & Net Debt Analysis